National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 326 cases where Vaccine is HPV4 and Patient Died

Case Details

This is page 15 out of 33

Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next


VAERS ID: 636334 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2009-05-01
Submitted: 2016-05-20
   Days after onset:2576
Entered: 2016-05-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1605USA009589

Write-up: Information was received from a physician via an internet article regarding cases in litigation concerning female patients of unknown age, who received vaccinations with GARDASIL (lot numbers, dates of vaccination, dosages, and routes of administration not reported). It was reported that between May 2009 and September 2010, 16 deaths occurred after GARDASIL vaccination (causes of deaths not reported). It was unknown if autopsies were performed. Upon internal review, 16 deaths was determined to be medically significant. This is one of several reports from the same source. Additional information is not expected.


VAERS ID: 639719 (history)  
Form: Version 1.0  
Age: 22.0  
Gender: Female  
Location: New York  
Vaccinated:2007-10-10
Onset:2009-12-01
   Days after vaccination:783
Submitted: 2016-06-16
   Days after onset:2388
Entered: 2016-06-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0515U / 1 RA / IM

Administered by: Other       Purchased by: Other
Symptoms: Abdominal discomfort, Alopecia, Amnesia, Anaemia, Antinuclear antibody, Autoimmune disorder, Fatigue, Full blood count, Headache, Mobility decreased, Muscular weakness, Oedema, Plasmapheresis, Scleroderma, Skin discolouration, Swelling face, Throat tightness, Thrombotic thrombocytopenic purpura, Vertigo, Visual impairment
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (broad), Anaphylactic reaction (narrow), Angioedema (narrow), Haematopoietic erythropenia (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Parkinson-like events (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Glaucoma (broad), Optic nerve disorders (broad), Cardiomyopathy (broad), Lens disorders (broad), Retinal disorders (broad), Vestibular disorders (narrow), Renovascular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 43 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: EXTREME FATIGUE, CONSTANT HEADACHES, AUTO IMMUNE DISEASES STARTING. STARTED BEING WORKED UP FOR LUPUS. CAME DOWN WITH A DANGEROUS CASE OF TTP AND NOW DEALING WITH A VERY SERIOUS CASE SCLERODERMA BECAUSE OF IT. NEVER HAD ANY OF THESE ISSUES BEFORE EVER.
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: ANA PANEL, CBC, ALL CAN BE PROVIDED.
CDC Split Type:

Write-up: HEADACHES, SEVERE FATIGUE, SKIN DISCOLORATION, MUSCLE WEAKNESS, SEVERE ANEMIA, FACE PUFFINESS, EDEMA, VERTIGO, HAIR LOSS, VISION CHANGES, MEMORY LOSS, SEVERE MOBILITY ISSUES, STOMACH DISCOMFORT, ESOPHAGUS TIGHTENING. GONE THROUGH IMMUNOSUPPRESSANTS, CELLCEPT, PLAQUENIL, RITUXAN TWICE, PLASMAPHERESIS EVER SINCE.


VAERS ID: 649444 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-26
Entered: 2016-08-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1606USA012148

Write-up: This spontaneous report was received from a physician via company representative, who saw an article by another physician. This report refers to 44 female patients of unknown age, whose concurrent conditions, medical history and concomitant medications were not known. On an unknown date, the patients were vaccinated with GARDASIL (details not known). As per the article the 44 patients died as a result of receiving GARDASIL and hence causality of death was considered to be related to the vaccine. The reporter considered the event serious (death). Upon internal review, death was considered to be medically significant. Additional information is not expected as the physician does not want to be contacted.


VAERS ID: 649671 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-29
Entered: 2016-08-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1608USA012926

Write-up: This spontaneous report was received from a physician via a company representative and refers to 44 female patients of unknown age. There was no information regarding the patients'' pertinent medical history, drug reactions, allergies or concomitant therapies provided. The physician found out about the event reported below from an online article. On unknown dates, the patients were vaccinated with doses of GARDASIL (lot #, expiration date, exact dose, site and route of administration were not reported). On unknown dates, the patients died as a result of receiving GARDASIL (also reported as they died from these vaccines). The relatedness between the event and GARDASIL was assessed as related. Upon internal review, the event of death was determined to be medically significant. This is one of two reports received from the same source. Additional information is not expected as there was no consent for follow-up.


VAERS ID: 650025 (history)  
Form: Version 1.0  
Age:   
Gender: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-08-31
Entered: 2016-08-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death, Guillain-Barre syndrome
SMQs:, Peripheral neuropathy (narrow), Guillain-Barre syndrome (narrow), Demyelination (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1608USA013930

Write-up: This spontaneous report was received from a physician via a company representative and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients'' pertinent medical history, concomitant medication and drug reactions or allergies was reported. The physician reported that she reviewed an unspecified article that described the patients, who, on unknown dates, were vaccinated with doses of GARDASIL (strength, dose, route of administration, anatomical location, lot# and expiration date were not provided). On unknown dates, an unspecified amount of time after the doses were administered, the patients were diagnosed with Guillain-Barre Syndrome and there were 44 deaths associated with GARDASIL. The outcome of Guillain-Barre syndrome was reported as unknown. The reporter considered death to be related to GARDASIL. The relatedness between Guillain-Barre syndrome and GARDASIL was not reported. Upon internal review, the events of Guillain-Barre syndrome and death were considered to be medically significant. Additional information has been requested.


VAERS ID: 651556 (history)  
Form: Version 1.0  
Age:   
Gender: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-09
Entered: 2016-09-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Unevaluable event
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609USA002304

Write-up: Information has been received from an unspecified person via a company employee referring to unknown number of patients of unknown age and gender. the patients'' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with GARDASIL (dose, lot #, expiration date and route not reported). the reporter stated that on unknown dates, the patients experienced pain and injury which caused by GARDASIL. Some patients also died due to the vaccine. the reporter stated that so many patient''s lives had been literally stolen from them due to GARDASIL. They could no longer play sports, dance, have fun and act like kids. the outcome of the events was unknown. the reporter considered the GARDASIL was related to the events. Upon internal review, the event of death was considered to be medically significant. This is one of several reports received from the same reporter. Additional information has been requested.


VAERS ID: 653657 (history)  
Form: Version 1.0  
Age:   
Gender: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-15
Entered: 2016-09-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609USA006280

Write-up: Information has been received from a molecular biology student, who obtained the information from a Vaccine Adverse Event Reporting System (VAERS) report, concerning 235 patients of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On unknown dates, the patients were vaccinated with unspecified doses of GARDASIL (strength, dosage schedule, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant medications were not provided. On unknown dates, the patients died. The causes of death were unknown, and it was also unknown whether autopsies were performed. The reporter indicated that he read the deaths were related to GARDASIL and he was concerned about the number of deaths reported for GARDASIL products. Upon internal review, death was determined to be medically significant. Additional information has been requested.


VAERS ID: 655947 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-09-29
Entered: 2016-09-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1609USA013034

Write-up: Information was received from a chief researcher through an online article via a company representative referring to 44 female patients of unknown age. The patients'' medical history, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with GARDASIL (lot#, expiration date, dose and route were unknown). On unknown dates, the patients died of this vaccine. The cause of death was unknown. It was unknown if autopsy was performed. The reporter considered death to be related to GARDASIL. Upon internal review, death was determined to be a medically significant event. This is one of several reports received from the same reporter. Additional information is not expected.


VAERS ID: 661043 (history)  
Form: Version 1.0  
Age:   
Gender: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2016-10-24
Entered: 2016-10-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1610USA011804

Write-up: This spontaneous report was received from a physician via company representative concerning 200 patients of unknown age and gender. The physician reported that an unspecified article provided information regarding patients who on dates were vaccinated with GARDASIL and died an unspecified time after vaccination. There was no product quality complaint reported. The reporter did not provide the causality assessment for the events. the cause of death was not specified. Upon internal review death was considered to be medically significant. Additional information has been requested.


VAERS ID: 671533 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2016-11-01
Submitted: 2016-12-12
   Days after onset:41
Entered: 2016-12-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Unknown       Purchased by: Unknown
Symptoms: Adverse event, Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2016-11-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US0095075131612USA005706

Write-up: This spontaneous report was received on 09-DEC-2016 from the grandmother of an 11 year old female who experienced adverse events after receiving GARDASIL (see case # 1612USA005619). The reporter stated that in November 2016 (reported as three and a half weeks ago), a friend of her grandaughter''s died. It was unclear from the statement whether this girl received GARDASIL before her death. Cause of death was not reported. Upon internal review, died was considered medically significant. Additional information is not expected as the reporter did not provide contact information. Sender''s Comments: US-009507513-1612USA005619: Reported Cause(s) of Death: died.


Result pages: prev   6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=15&VAX[]=HPV4&DIED=Yes


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166